Announcing Outcome Measures: A Collection of ICON Services to Advance Patient-Centered Clinical Trials

September 3, 2024 - Today, Mapi Research Trust sponsor ICON announced the launch of its innovative Outcome Measures service. This comprehensive solution is designed to transform clinical research by placing patients at the core of the research process, in response to the growing emphasis on patient-centricity in drug development. 

Core to this new service within ICON is Mapi Research Trust’s expertise on Clinical Outcome Assessments (COAs). Mapi Research Trust maintains the industry's largest database of COA information, with exclusive distribution of 800+ COAs, and licensing, distribution, and consultancy services for many widely-used instruments. 

Another component of Outcome Measures AI-powered biomarkers and digital health technologies provided through Atlas, the most comprehensive platform for digital measures, covering 18,000+ digital measures and 3,600 digital health technologies across 1,700 clinical trials.

Rounding out Outcome Measures are ICON’s eCOA implementation and linguistic validation capabilities and expertise.

By combining these comprehensive services under one unified umbrella, ICON’s Outcome Measures enables researchers to design trials that truly reflect patient needs and experiences. We are proud to be supporting more patient-centered clinical research.